The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 12th September 2022, starting at 10:30 BST and will finish at 14:30 BST with a reception.

The Roche Pharma Day will address the following topics:

 

 

  • Pharma strategy, portfolio planning, productivity & new technologies
  • Market opportunities, on-going launches, pricing & access
  • Late stage pipeline update in oncology, neuroscience, immunology, infectious diseases & ophthalmology

 

Speakers will include Bill Anderson, Teresa Graham, Levi Garraway, Paulo Fontoura and Christopher Brittain. You will have the opportunity to meet senior management during the event.

Meeting information: 
Date/Time (BST):
Monday, 12th September 2022
10:00 Registration
10:30 Event starts
14:30 Event ends, followed by a reception with Roche Management Team

Venue
etc.venues St Paul’s
200 Aldersgate
London EC1A 4HD
map

Registration has closed, please send an email to investor.relations@roche.com if you still want to register for the onsite event.

 

The slides will be available for download at 9:30 BST on the day of the event. 
> click here

 

Alternatively you may participate virtually in the webinar. (no access to speakers, pre-registration required)
Please pre-register for the webinar here*. 

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

 

A replay of the event will be available via > ir.roche.com
*privacy notice

 

Best regards,

 

 

Bruno Eschli 
Head of Investor Relations

 
  


 

Roche Investor Relations 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

 


get the latest news and updates to your inbox.